Skip to content
Trial Eligibility
Menu

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

NCT03932773

This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Post Traumatic Stress Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 60 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
The University of Texas at Dallas
Last updated on ClinicalTrials.gov
August 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Florida State University College of Medicine · Tallahassee, FL

Texas · 2

  • Metrocare Services of Dallas · Addison, TX
  • The University of Texas at Dallas · Dallas, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.